Journal of Cystic Fibrosis
Volume 9, Issue 4 , Pages 296-297, July 2010

Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: Three areas for future research:

Which areas to target? Which particle size to deliver? Which device to use?

  • Bart L. Rottier

      Affiliations

    • Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, The Netherlands
    • ,
  • Anne H. de Boer

      Affiliations

    • Department of Pharmaceutical Technology and Biopharmacy, University of Groningen, The Netherlands
    • ,
  • Eric J. Duiverman

      Affiliations

    • Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, The Netherlands

Received 7 December 2009; received in revised form 23 March 2010; accepted 24 March 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1569-1993(10)00036-6

doi:10.1016/j.jcf.2010.03.009

Journal of Cystic Fibrosis
Volume 9, Issue 4 , Pages 296-297, July 2010

Article Tools